Back to results
US 2021/0228523 A1Published application
Modulators of sestrin-gator2 interaction and uses thereof
AssigneeNavitor Pharmaceuticals, Inc.
InventorsEddine SAIAH, George VLASUK
Life of this patent
Estimating the term…
Abstract
The present invention provides compounds, compositions thereof, and methods of using the same.
Claims18
A method of treating treatment-resistant depression in a patient in need thereof, said method comprising administering to said patient a compound of formula I-90 or a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable composition thereof:
- in combination with an antidepressant therapeutic agent.
2-20. (canceled)
Dependencies are inferred from the claim text.